ArticleCellular and molecular life sciences : CMLS2020

Drug repurposing studies of PARP inhibitors as a new therapy for inherited retinal degeneration.

Ayse Sahaboglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.